T-knife

Description: T-knife uses its HuTCR mouse platform to develop fully human TCRs for cancer treatment, with preclinical success & multiple drug candidates.

Country: Germany

Based in: Berlin

Founded: 2018

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Medical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.